Comorbidity among inpatients with dementia: a preliminary cross-sectional study in West China

被引:8
作者
Xiao, Xiaoqiang [1 ,3 ,4 ]
Xiang, Shunju [5 ,6 ]
Xu, Qingya [1 ,3 ,4 ]
Li, Jieying [1 ,3 ,4 ]
Xiao, Jun [1 ,3 ,4 ]
Si, Yang [2 ,4 ]
机构
[1] Sichuan Acad Med Sci, Sichuan Peoples Hosp, Dept Neuropsychol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Acad Med Sci, Sichuan Peoples Hosp, Dept Neurol, 32 W Sec 2, 1St Ring Rd, Chengdu 610072, Sichuan, Peoples R China
[3] Sichuan Prov Ctr Mental Hlth, Chengdu, Sichuan, Peoples R China
[4] Univ Elect Sci & Technol China, Chengdu, Sichuan, Peoples R China
[5] West China Hosp, Dept Anesthesiol, Chengdu, Peoples R China
[6] Sichuan Univ, West China Sch Nursing, Chengdu, Peoples R China
关键词
Dementia; Alzheimer's disease; Vascular dementia; Risk; Comorbidity index; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; ELDERLY-PATIENTS; RISK; POLYPHARMACY; ASSOCIATION; MORTALITY; EPILEPSY; CANCER; EPIDEMIOLOGY;
D O I
10.1007/s40520-023-02349-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
ObjectiveTo investigate comorbidities among hospitalized patients with dementia.MethodData were extracted from the discharge records in our hospital. Comorbidities based on ICD-10 were selected from the Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI). The distributions of these comorbidities were described in dementia inpatients and age- and sex-matched nondementia controls, as well as in inpatients with Alzheimer's disease and vascular dementia. A logistic regression model was applied to identify dementia-specific morbid conditions.ResultsA total of 3355 patients with dementia were included, with a majority of 1503 (44.8%) having Alzheimer's disease, 395 (11.8%) with vascular dementia, and 441 (13.1%) with mixed dementia. The mean number of comorbidities was 3.8 in dementia patients (vs. 2.9 in controls). The most prevalent comorbidities in inpatients with dementia compared with those without dementia were cerebral vascular disease (73.0% vs. 35.9%), hypertension (62.8% vs. 56.2%), and peripheral vascular disease (53.7% vs. 31.2%). Comorbidities associated with dementia included epilepsy (OR 4.8, 95% CI 3.5-6.8), cerebral vascular disease (OR 4.1, 95% CI 3.7-4.5), depression (OR 4.0, 95% CI 3.2-5.0), uncomplicated diabetes (OR 1.5, 95% CI 1.4-1.7), peripheral vascular disease (OR 1.8, 95% CI 1.6-2.0), rheumatoid arthritis collagen vascular disease (OR 1.7, 95% CI 1.3-2.3), and anemia (OR 1.2, 95% CI 1.04-1.3). Some comorbidities suggested a protective effect against dementia. They were hypertension (OR 0.8, 95% CI 0.7-0.9), COPD (OR 0.6, 95% CI 0.5-0.6), and solid tumor without metastasis (OR 0.4, 95% CI 0.3-0.4). Vascular dementia has more cardiovascular and cerebrovascular comorbidities than Alzheimer's disease.ConclusionPatients with dementia coexisted with more comorbidities than those without dementia. Comorbidities (esp. cardio-cerebral vascular risks) in patients with vascular dementia were more than those in patients with AD. Specifically, vascular and circulatory diseases, epilepsy, diabetes and depression increased the risk of dementia.
引用
收藏
页码:659 / 667
页数:9
相关论文
共 63 条
  • [1] Alic Alma, 2011, Med Arh, V65, P102
  • [2] Anaemia and cognitive performances in the elderly: a systematic review
    Andro, M.
    Le Squere, P.
    Estivin, S.
    Gentric, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (09) : 1234 - 1240
  • [3] Towards a Consensus on Alzheimer's Disease Comorbidity?
    Avitan, Iska
    Halperin, Yudit
    Saha, Trishna
    Bloch, Naamah
    Atrahimovich, Dana
    Polis, Baruh
    Samson, Abraham O.
    Braitbard, Ori
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [4] Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
    Barnett, Karen
    Mercer, Stewart W.
    Norbury, Michael
    Watt, Graham
    Wyke, Sally
    Guthrie, Bruce
    [J]. LANCET, 2012, 380 (9836) : 37 - 43
  • [5] Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia
    Barus, Romain
    Bene, Johana
    Deguil, Julie
    Gautier, Sophie
    Bordet, Regis
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (18) : 3413 - 3434
  • [6] National Norms for the Elixhauser and Charlson Comorbidity Indexes Among Hospitalized Adults
    Boogaerts, Garner
    Loyd, Christine
    Zhang, Yue
    Kennedy, Richard E.
    Brown, Cynthia J.
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2023, 78 (02): : 365 - 372
  • [7] Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study
    Browne, Jorge
    Edwards, Duncan A.
    Rhodes, Kirsty M.
    Brimicombe, D. James
    Payne, Rupert A.
    [J]. BMJ OPEN, 2017, 7 (03):
  • [8] Comorbidity and dementia: a scoping review of the literature
    Bunn, Frances
    Burn, Anne-Marie
    Goodman, Claire
    Rait, Greta
    Norton, Sam
    Robinson, Louise
    Schoeman, Johan
    Brayne, Carol
    [J]. BMC MEDICINE, 2014, 12
  • [9] Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry
    Cermakova, Pavla
    Fereshtehnejad, Seyed-Mohammad
    Johnell, Kristina
    Winblad, Bengt
    Eriksdotter, Maria
    Religa, Dorota
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (03):
  • [10] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383